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BACKGROUND: Over the past few years, we have witnessed a 
dramatic increase in the number of patients presenting with severe 
pancytopenia to Jimma University Hospital. We now present socio-
demographic and clinical characteristics of adult patients admitted 
with pancytopenia of unknown cause to Jimma University Hospital 
during the period of March 2015 to June 2016. Complete blood count 
and other diagnostic tests were done for all patients to uncover 
underlying causes.  
RESULT: Out of 65 cases admitted with pancytopenia during the 
specified period, 40 were excluded for various reasons. The rest 25 
patients were included in this review. The mean age was 32.1 years 
(SD=14.9); 14 were younger than 30 years of age. The mean 
hemoglobin level, white cell count and platelet count were 48.6 g/L 
(SD=1.9), 1,918 /µL (SD=879.8) and 36,200 /µL (SD=26,131) 
respectively.  The major presenting symptoms were generalized 
malaise and fever. No geographic or seasonal clustering of the cases 
was seen. 
CONCLUSION: The number of cases with pancytopenia of 
unidentified cause seen at the hospital over the specified period is 
alarmingly high and deserves great attention. The hematologic 
alteration in most of the patients was found to be severe with poor 
clinical outcome. This calls for large scale community based 
investigation to uncover the root cause of the problem. 




Pancytopenia is a clinical phenomenon characterized by reduction in the 
levels of all the three types of blood cells-erythrocytes, leukocytes and 
platelets.  It is not a disease entity on its own but a triad of cytopenias 
originating from various disease processes (1). Pancytopenia can be due 
to bone marrow failure, immune mediated destruction of cells or 
sequestration in peripheral tissues (2).  Aplastic anemia, acute 
leukemias, bone marrow fibrosis, myelodysplastic syndrome and 
infiltrative diseases mainly due to malignant cells are major causes of 
bone marrow failure. Hypersplenic state, systemic lupus erythematosus, 
infections (Tuberculosis, HIV, leishmaniasis and brucellosis) and 
nutritional deficiency (folate, B12) are non-marrow disorders associated 
with pancytopenia (2). 
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Even though causes of pancytopenia exhibit 
substantial geographic variations, aplastic anemia 
is the commonest cause of pancytopenia 
worldwide (3,4). Aplastic anemia can be inherited 
or acquired. Acquired aplastic anemia due to 
drugs, viral infections, various organic compounds 
and radiation is by far the commonest form (2). 
However, more than half of the patients with 
aplastic anemia do not have known causes (2,5,6). 
Moreover, the pathophysiologic mechanisms of 
aplastic anemia in some of the known causes like 
certain drugs and virus is not well known (2).  
Chemotherapeutic agents, antibiotics 
(chloramphenicol, sulphonamides), antiepileptic 
drugs (Carbamazepine, Phenytoin, Valproic acid), 
and heavy metals such as gold are known 
therapeutic agents associated with increased risk 
of aplastic anemia. Virus such as parvovirus B19, 
hepatitis viruses (non-A, non-B, non-C, non-G 
hepatitis) and HIV are known viral causes of 
aplastic anemia (2,7). Aplastic anemia due to 
exposure to industrial chemicals, pesticides and 
insecticides such as benzene hexacholride 
(lindane) are also well documented (8-11). 
Pesticide and insecticide related aplastic anemia 
often affects young and working country-side men 
in low income settings who have prolonged 
exposure to these chemicals (9,12,13). However, 
the contribution of these organic agents is often 
overlooked and data, from sub-Saharan Africa in 
particular, remain scarce. 
There are no specific signs and symptoms for 
pancytopenia. Clinical presentations are directly 
proportional to the severity of the underlying 
cytopenias as well as the etiology (14). Patients 
with mild cytopenia are often asymptomatic (15). 
The majority of symptoms are related to the severe 
anemia and catabolic state. As a result, the 
commonest presenting symptom is generalized 
weakness. Dyspnea, fever and weight loss are also 
common (15,16). Furthermore, patients with 
severe thrombocytopenia may present with 
bleeding diathesis (15).   
Management and prognosis of pancytopenia 
is complex and depends on underlying 
pathophysiology and patient related factors (15). 
Supportive management including treatment of the 
anemia, thrombocytopenia and infections are 
important life-saving emergency treatments. 
Pancytopenias due to nutritional deficiencies like 
megaloblastic anemia are readily treatable and 
reversible (16). However, the clinical outcome 
largely depends on the severity of the 
pancytopenia, age of the patient and the causes. 
Hence, identifying the underlying etiology is 
essential for proper management and to improve 
long term outcome (17,18).   
Over the last few years, we have witnessed a 
dramatic increase in the number of cases 
presenting with severe pancytopenia admitted to 
Jimma University Hospital. Many of these patients 
were young and did not have known causes or 
identifiable risk factors for pancytopenia. Because 
of limited diagnostic capacity to uncover 
underlying causes, the management of these 
patients remains very challenging for physicians. 
The objective of this review was to describe the 
sociodemographic and clinical characteristics of 
patients admitted to the hospital with pancytopenia 
of unknown causes during a period of 16 months. 
The main goal is to provide clinical summary and 
baseline information to initiate large scale 
epidemiologic investigation and interventions for 




This case series survey was conducted at Jimma 
University Hospital in southwest Ethiopia. Data 
were collected both retrospectively and 
prospectively. Patients included in the survey were 
those admitted to medical wards of the hospital 
between March 2015 and June 2016. For patients 
admitted between March to December, 2015, data 
was collected retrospectively. For patients 
admitted after that, data was collected 
prospectively.  
Cases included in this review were selected 
based on the following inclusion criteria: 
1. Leukopenia, white cell count <4000 cell/µL 
2. Anemia, hemoglobin <100 g/L   
3. Thrombocytopenia, platelet count <100,000 
cells/µL 
Patients with known or suspected causes of 
pancytopenia were excluded from this review. As 
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a result, patients with confirmed or possible 
diagnosis of any of the following were not 
included: 
1. Any hypersplenic state (massive 
splenomegaly)-e.g., hyperactive malaria 
splenomegaly, portal hypertension 
(hepatosplenic schistosomiasis) 
2. Megaloblastic anemia  
3. Hematologic malignancies (lymphomas and 
leukemias) 
4. Confirmed solid organ malignancy 
5. HIV infection 
6. Disseminated tuberculosis (miliary 
tuberculosis) 
7. Decompensated chronic liver disease 
8. Patients taking any drug known to cause 
pancytopenia (chemotherapy, sulfonamides, 
etc.) 
9. Severe systemic bacterial infections (e.g., 
sepsis of any source) 
10. Serologically confirmed acute viral hepatitis 
11. Severe iron deficiency state 
12. Systemic lupus erythematosus and any 
known autoimmune disorder 
13. Visceral leishmaniasis (suspected or 
confirmed) 
Sociodemographic characterises and presenting 
clinical symptoms were retrieved through patient 
interview where applicable or chart review in 
retrospective cases.  Patients were thoroughly 
screened for inclusion and exclusion criteria 
through history-taking/chart review, physical 
examination and laboratory parameters. All 
patients had complete blood count by coulter 
counter, erythrocyte sedimentation rate (ESR) and 
liver enzymes. They were also offered rapid HIV 
test. Peripheral morphology was also done, and 
other diagnostic investigations were performed to 
exclude potential causes of 
anemia/leukopenia/thrombocytopenia. Information 
collected through interview and physical 
examination of the patient and all diagnostic tests 
performed were done only as part of routine 
patient care. Outcome at leaving hospital was 
documented for length of hospital stay, discharge 





Sociodemographic and clinical characteristics 
of the cases: During the period of March 2015 to 
June 2016, 65 patients were admitted to the 
hospital with diagnosis of pancytopenia. Forty 
patients were excluded because they either had 
known underlying causes or were not fully 
worked-up, or their medical records were lost.  
The rest 25 patients were included in this review. 
The mean age of those included was 32.1 years 
(SD=14.9) with range of 16 to 72. Fourteen (56%) 
were younger than 30 years while only two 
patients were older than 50. Nearly two-third (16) 
were male patients. Seventeen patients (68%) 
were rural residents; six were from urban/semi-
urban settings whereas two were from refugee 
camp in Gambella Region.  
Duration of illness before presentation  
ranged from 2 to 60 days with mean of 23.5 days 
(SD=18.7). The major presenting symptoms were 
malaise and easy fatigability reported in all of the 
patients. Fever and vomiting were the other 
common symptoms reported in 14 and 7 patients 
respectively (Table 1).  
 
Table 1: Presenting clinical symptoms of patients 
treated for pancytopenia of unknown cause at 
Jimma University Hospital. 
 
Symptoms  Number  Percent  
Generalized fatigability  25 100 
Fever 14 56 
Vomiting  7 28 
Edema  6 24 
Headache  4 16 
Decreased appetite  3 12 
Epistaxis  3 12 
Jaundice  1 4 
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With regard to comorbidities identified, two 
patients were on treatment for major depressive 
disorder with tricyclic antidepressant; one patient 
had established chronic renal insufficiency and 
another had chronic viral hepatitis (positive 
serology only). One patient was pregnant. None of 
the patients were using any illicit drug or herbal 
treatment prior to their illnesses.  
On examination, 13 patients (52%) had 
objectively detected fever on arrival and three 
presented with low blood pressure. Hepatomegaly, 
spleanomegaly, and axillay lymphadenopathy 
were detected in 5, 4, and 2 patients respectively. 
Jaundice and petechial rash were detected in one 
patient each.  
All of the patients had peripheral complete 
blood count using Coulter counter. The mean 
white cell count was 1,918 /µL (SD=879.8) with 
range of 500 to 3,700 /µL. All of the patients had 
absolute neutrophil count of less than 1,500 /µL; 
seven had counts less than 500 / µL.  The mean 
hemoglobin was 48.6 g/L (SD=1.9) ranging 
between 17 and 93 g/L. Twenty-three of the 
patients (92%) had severe anemia (hemoglobin < 
80 g/L). The mean platelet count was 36,200 /µL 
(SD=26,131) with range of 2,000 to 93,000. 
Eighteen patients had count less than 50,000 /µL 
and eight had count less than 20,000 /µL.  
Peripheral morphology was evaluated for all 
of the patients. No morphologic abnormality of 
nucleated cells was noted. Tear drops and 
fragmented RBCs were reported in few patients. 
The mean cell volume was 97.9 (SD=11) with 
range of 83.5 to 118.4 fl; nine patients had mild 
macrocytosis.  
Erythrocyte sedimentation rate (ESR) was the 
only acute phase reactant tested in the patients. 
Most of them had a very high rate with mean of 
108.1 mm in the first hour (SD=46.4) and range of 
40 to 165 mm in the first hour. 
Liver enzymes aspartate aminotransferase (AST) 
and alanine aminotransferase (ALT) were assessed 
in all of the patients. Eleven patients had 
increment in AST (from slight elevation to 17 fold 
increment from normal upper limit of the 
laboratory in two patients). Six patients had raised 
ALP from mild elevation to about 24 fold of 
normal upper limit. Five patients had 
hyperbilirubinemia. Serum protein level was 
reported for four patients only; all had lower than 
normal values. All the three patients who had 
coagulation assay also had elevated prothrombin 
time. However, serologic screening for hepatitis B 
and hepatitis C viruses was negative except in one 
patient who had positive hepatitis B surface 
antigen who otherwise had normal liver enzyme 
level.   
Ultrasound of abdomen was normal for all 
except for those with hepatomegaly and 
splenomegaly. Blood film for hemoparasite was 
repeatedly performed for all of these patients and 
was found to be negative in all.  
 
Treatment and outcome of the cases: Twenty-
two patients were transfused with one or more 
units of compatible whole blood, and 17 of them 
were empirically given intravenous ceftriaxone 
alone or in combination with other antibiotics. 
Four patients (16%) died in the hospital; 12 (48%) 
left the hospital without any improvement (five of 
them were referred for better care and six self-
discharged). Only 9 (36%) were discharged with 
some improvement; cell counts in some of these 
patients significantly improved. 
Geographic and seasonal variation of cases: 
The cases were from Jimma and Illubabor zones 
of Oromiya Region, Keffa and Sheka zones of 
South Nations and Nationalities Region, and 
Gambella Region. More than half of the patients 
were from Jimma Zone due to  proximity to the 
hospital. However, there is no clustering of cases 
to specific village, kebele or wereda (Figure 1).  
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Figure 1: Map of Southwest Ethiopia region illustrating the origin of patients who presented to 
Jimma University Hospital with pancytopenia 
 
Similarly, there is no clear seasonal variation seen 
even though the number of cases was found to be 
higher between December and March (Figure 2). 
This is most likely due to selection bias; data was 
collected retrospectively for patients presenting 
before January 2016 and prospectively after that. 
As we tried to include only patients with complete 
data in retrospective cases, the number included 
here is likely to be an underestimate of real 
number of cases. 
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Pancytopenia of unknown cause was found to be a 
common clinical phenomenon at the hospital 
during the survey period. Most of the patients 
admitted with the problem were young 
countryside men presenting with severe 
pancytopenia. No geographic clustering of the 
cases was seen with patients presenting from wide 
areas of southwestern Ethiopia. The underlying 
causes were not identifiable despite multiple 
diagnostic tests. The discharge outcome was found 
to be very poor with only 9 (25%) patients having 
improvement on leaving hospital; the overall in-
hospital mortality rate was 16%. This shows that 
pancytopenia is now a serious and common 
medical condition in the area. The cause in many 
patients is unknown and thus the treatment 
remains obscure.   
The reported number of cases during the 
period is likely to be an underestimate due to lost 
records. Moreover, it should be noted that none of 
the patients had bone marrow examination and 
that some of them might have had known causes. 
The findings of individual patients in this case 
review does not imply whether the underlying 
pathology is bone marrow failure or peripheral 
destruction. However, due to the fact that patients’ 
presentation was related only to the pancytopenia 
and the absence of other comorbid condition may 
reflect primary bone marrow affection. Although 
the evaluation of these cases falls short of standard 
investigation for pancytopenia, the absence of 
known causes with available tests may support 
diagnosis of aplastic anemia (2,5,6). 
Most of our patients were rural residents with 
poor economic status. Even though this by itself 
may not imply any underlying cause, 
environmental factors are likely contributors of the 
major pathophysiology. Multiple factors may 
contribute to such environmental factors for 
aplastic anemia (19), and low socioeconomic 
status may be a surrogate for environmental 
factors such as infectious pathogens or toxin 
exposures (20). The absence of geographic 
clustering and seasonal variability shows the 
diverse occurrence of the problem. Thus, 
investigation for the root cause of this 
geographically widespread problem should put in 
to consideration the possibility of commonly used 
environmental toxins (such as pesticides and 
insecticides) and infectious conditions such as, but 
not limited to, vector born viral infections.  
Whether the mild hepatocellular alterations as 
evidenced by elevated liver enzymes and serum 
bilirubin in some of the patients is an association 
or coincidental occurrence was not thoroughly 
investigated in these patients. Nevertheless, 
hepatitis associated aplastic anemia (21) and 
environmental exposure to pesticides and 
insecticides (22) may explain such clinical 
scenario.  However, because of the limitations of 
this review, we are reserved from making any 
conclusion from these associations. 
Only about a third of the patients had a 
reported clinical and hematologic improvement on 
discharge. In addition, many patients left the 
hospital with poor clinical status. Even though the 
in-hospital mortality rate was only 16%, it is 
possible to extrapolate that the mortality in these 
cases is likely to be much higher. Most affected 
patients were young and in the productive age 
group reflecting a huge clinical and economic 
consequence of the problem and hence deserves 
utmost attention from all stakeholders.   
In conclusion, the number of cases with 
pancytopenia of unidentified cause seen at the 
hospital over the specified period is alarmingly 
high and of great concern. Even at the time of 
writing of this report, there were still cases with 
similar clinical presentations. The hematologic 
alteration in most of the patients was found to be 
very grave with severe clinical conditions. It is 
thus mandatory for all stakeholders (the hospital, 
local health offices, regional health bureau and 
Federal Ministry of Health) to screen all such 
cases for possible underlying etiologies. Large 
scale investigation is essential to reach to the 
culprit cause and take emergent public health 
intervention.  
Our review of this case series has multiple 
limitations worth mentioning here. Only patients 
with complete medical records were included in 
this survey. Moreover, only patients admitted to 
the hospital were included leaving for the 
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possibility of significant selection bias. 
Additionally, bone marrow examination was not 
done for all of them, and hence, the real 
pathophysiology cause of pancytopenia could not 
be established. Absence of toxicological and 
virologic screening for possible underlying causes 
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